Soros to Buy $40 Million of Sihuan Pharma’s Hong Kong IPO

According to press reports, George Soros, the billionaire international investor, has committed $40 million to Sihuan Pharma’s upcoming Hong Kong IPO, one of six cornerstone investors in the offering. Sihuan, China’s largest cardio-cerebral vascular drugmaker, plans to raise $749 million in its IPO. More details.... Stock Symbol: (HK: 0460)